Nomination Committee

The principles states that the Nomination Committee shall consist of representatives of the three largest shareholders in Vicore Pharma as of 31 August 2025 together with the Chairman of the Board.

The Nomination Committee for the Annual General Meeting 2026 consisted of Staffan Lindstrand as representative of HealthCap VII L.P., Jan Särlvik as representative of Fourth Swedish National Pension Fund, Ivo Staijen as representative of HBM Healthcare Investments (Cayman) Ltd and Hans Schikan, Chairman of the Board.

The task of the Nomination Committee is to prepare and present proposals for the number of Board members to be elected by the AGM, the election of a Chairman and other members of the Board, board fees, remuneration for committee work, election of a Chairman to the Annual General Meeting, election of auditors (if applicable) and auditors fees (if applicable) and proposals for rules for the appointment of a nomination committee for the Annual General Meeting 2027.

The Annual General Meeting of Vicore Pharma Holding AB (publ) took place on May 6, 2026.